Table 1.
COVID-19 vaccine approved by at least one country
| Vaccine name Developers |
Type | Approved |
|---|---|---|
|
EpiVacCorona Vector State Research Centre of Virology and Biotechnology |
Protein subunit (peptide antigen) | Russia |
|
BNT162b2/CMIRNATY BioNTech/Pfizer |
Nucleoside-modified mRNA | Bahrain, New Zealand, Saudi Arabia, Switzerland, Argentina, Australia, Canada, Chile, Colombia, Costa Rica, Ecuador, European Union, Iceland, Iraq, Israel, Jordan, Kuwait, Lebanon, Malaysia, Mexico, Mongolia, Norway, Oman, Panama, Peru, Philippines, Qatar, Serbia, Singapore, Tunisia, United Arab Emirates, UK, USA, South Korea |
|
mRNA-1273 Moderna |
mRNA-based vaccine encapsulated in lipid nanoparticle (LNP) | Switzerland, Canada, European Union, Iceland, Israel, Mongolia, Norway, Qatar, Singapore, UK, USA |
|
Ad5-nCoV CanSino Biologics |
Recombinant novel coronavirus Vaccine (adenovirus type 5 vector) Non-replicating viral vector |
Mexico, China |
|
Sputnik V Gamaleya Research Institute |
Human adenovirus vector-based COVID-19 vaccine Non-replicating viral vector |
Russia, Algeria, Argentina, Armenia, Bahrain, Belarus, Bolivia, Bosnian Serb Republic, Guinea, Hungary, Iran, Kazakhstan, Lebanon, Mexico, Mongolia, Myanmar, Nicaragua, Pakistan, Palestinian Authority, Paraguay, Serbia, Tunisia, Turkmenistan, United Arab Emirates, Venezuela |
| AZD1222 Oxford/AstraZeneca |
Recombinant replication defective chimpanzee adenovirus expressing the SARS-Cov-2 S surface glycoprotein Non-replicating viral vector |
Algeria, Argentina, Bangladesh, Bhutan, Brazil, Chile, Dominican Republic, Egypt, El Salvador, European Union, Iceland, India, Iraq, Kuwait, Maldives, Mexico, Mongolia, Morocco, Nepal, Norway, Pakistan, Philippines, Seychelles, Sri Lanka, South Africa, South Korea, Thailand, UK |
|
Covishield (ChAdOx1_nCov-19) Serum Institute of India |
Recombinant ChAdOx1 adenoviral vector encoding the spike protein antigen of the SARS-CoV-2 Non-replicating viral vector |
Argentina, Bahrain, Bangladesh, India, Maldives, Morocco, Nepal, South Africa, Sri Lanka |
|
Covaxin Bharat Biotech |
Inactivated | India |
|
BBIBP-CorV SARS-Cov-2 Vaccine (Vero Cell) Sinopharm |
Inactivated | Bahrain, China, United Arab Emirates, Cambodia, Egypt, Hungary, Iraq, Jordan, Pakistan, Peru, Serbia, Seychelles |
|
Inactivated (InCov) Sinopharm |
Inactivated | China, United Arab Emirates |
|
CoronaVac Sinovac Biotech |
Inactivated | China, Azerbaijan, Brazil, Chile, Colombia, Indonesia, Laos, Turkey, Uruguay |